Terms: = Myeloproliferative Neoplasm AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Diagnosis
1451 results:
1. Late presentation of chronic myeloid leukaemia patients in a low-income country: the prognostic implications and impact on treatment outcome.
Nelson EA; Ahmed IO; Bolarinwa RA; Adeagbo BA; Adegbola AJ; Salawu L; Bolaji OO; Durosinmi MA
BMC Res Notes; 2024 Sep; 17(1):245. PubMed ID: 39227850
[TBL] [Abstract] [Full Text] [Related]
2. Gene Variants in Components of the microRNA Processing Pathway in Chronic Myeloid Leukemia.
Chavaro-Francisco G; Hernández-Zavala A; Bravo-Cidro CE; Rios-Rodriguez S; Muciño-Sánchez M; López-López M; Castro-Martínez XH; Olarte-Carrillo I; Garcia-Laguna A; Barranco-Lampón G; De la Cruz-Rosas A; Martínez-Tovar A; Córdova EJ
Genes (Basel); 2024 Aug; 15(8):. PubMed ID: 39202414
[TBL] [Abstract] [Full Text] [Related]
3. Cytogenetics and genomics in CML and other myeloproliferative neoplasms.
Kreipe HH; Schlegelberger B
Best Pract Res Clin Haematol; 2024 Jun; 37(2):101552. PubMed ID: 39098796
[TBL] [Abstract] [Full Text] [Related]
4. Bone marrow fibrosis in newly diagnosed multiple myeloma and its correlation with clinicopathological factors.
Hu X; Dai X; Guo X; Jiang X; Li Y; Zhao H; Lu J; Li X; Jin M
Diagn Pathol; 2024 Jul; 19(1):99. PubMed ID: 39026319
[TBL] [Abstract] [Full Text] [Related]
5. Clinical Characteristics and diagnosis of Nonaccelerating MDS/MPN-U Patient with Granulocyte Dysplasia.
Jin N; Li S
Clin Lab; 2024 Jul; 70(7):. PubMed ID: 38965949
[TBL] [Abstract] [Full Text] [Related]
6. CSF3R mutated myeloid neoplasms: Beyond chronic neutrophilic leukemia.
Mohamed A; Gao J; Chen YH; Abaza Y; Altman J; Jennings L; Vormittag-Nocito E; Sukhanova M; Lu X; Chen Q
Hum Pathol; 2024 Jul; 149():66-74. PubMed ID: 38879086
[TBL] [Abstract] [Full Text] [Related]
7. Red cell distribution width and prognosis in myelofibrosis patients treated with ruxolitinib.
Cattaneo D; Galli N; Bucelli C; Fidanza CA; Bellani V; Artuso S; Bianchi P; Consonni D; Passamonti F; Iurlo A
Ann Hematol; 2024 Aug; 103(8):2787-2795. PubMed ID: 38864904
[TBL] [Abstract] [Full Text] [Related]
8. Allogeneic haematopoietic cell transplantation for chronic myeloid leukaemia in Switzerland in the face of rapid development of effective drugs.
Heim D; Baldomero H; Medinger M; Masouridi-Levrat S; Schanz U; Nair G; Güngör T; Halter J; Passweg JR; Chalandon Y;
Swiss Med Wkly; 2024 May; 154():3754. PubMed ID: 38749067
[TBL] [Abstract] [Full Text] [Related]
9. Analytical validation of the DropXpert S6 system for diagnosis of chronic myelocytic leukemia.
Wei W; Li S; Zhang Y; Deng S; He Q; Zhao X; Xu Y; Yu L; Ye J; Zhao W; Jiang Z
Lab Chip; 2024 Jun; 24(12):3080-3092. PubMed ID: 38747247
[TBL] [Abstract] [Full Text] [Related]
10. Therapeutic Choices in Patients with Ph-Positive Chronic Myelogenous Leukemia In Mexico in the Era of Tyrosine Kinase Inhibitors: Stem Cell Transplantation or Tyrosine Kinase Inhibitors? Fifteen Years Later.
Robles-Nasta M; Sánchez-Bonilla D; Gallardo-Pérez MM; Hernández-Flores EJ; Montes-Robles MA; Pastelín-Martínez ML; Olivares-Gazca JC; Ruiz-Delgado GJ; Ruiz-Argüelles GJ
Rev Invest Clin; 2024; 76(2):91-96. PubMed ID: 38740380
[TBL] [Abstract] [Full Text] [Related]
11. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management.
Szuber N; Orazi A; Tefferi A
Am J Hematol; 2024 Jul; 99(7):1360-1387. PubMed ID: 38644693
[TBL] [Abstract] [Full Text] [Related]
12. Ponatinib and STAT5 Inhibitor Pimozide Combined Synergistic Treatment Applications Potentially Overcome Drug Resistance via Regulating the Cytokine Expressional Network in Chronic Myeloid Leukemia Cells.
Tezcanli Kaymaz B; Gumus N; Celik B; Alcitepe İ; Biray Avci C; Aktan C
J Interferon Cytokine Res; 2024 Apr; 44(4):178-189. PubMed ID: 38579140
[TBL] [Abstract] [Full Text] [Related]
13. [Discontinuation of tyrosine kinase inhibitors before epiphyseal closure leading to improved short stature in pediatric chronic myelogenous leukemia].
Fukui W; Ogura T; Azumi S; Ogata H; Kawaguchi K; Takachi T; Horikoshi Y; Uematsu A; Shimada H; Watanabe K
Rinsho Ketsueki; 2024; 65(3):175-179. PubMed ID: 38569862
[TBL] [Abstract] [Full Text] [Related]
14. Triple-Negative Myelofibrosis: Disease Features, Response to Treatment and Outcomes.
Aguirre LE; Jain A; Ball S; Ali NA; Volpe VO; Tinsley-Vance S; Sallman D; Sweet K; Lancet J; Padron E; Yun S; Kuykendall A; Komrokji R
Clin Lymphoma Myeloma Leuk; 2024 Jul; 24(7):459-467. PubMed ID: 38548563
[TBL] [Abstract] [Full Text] [Related]
15. The Screening of microRNAs in Chronic Myeloid Leukemia: A Clinical Evaluation.
Wosniaki DK; Marin AM; Oliveira RN; Koerich GM; Munhoz EC; Farias JSH; Beltrame MP; Zanette DL; Aoki MN
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542337
[TBL] [Abstract] [Full Text] [Related]
16. Spotlight on the real-world treatment of CML pts in Germany: a retrospective survey in private oncology practices.
Franke GN; Loewe G; Reiser M; Linde H; Josting A; von der Heyde E; Platzbecker U; Weide R; Tesch H; Nusch A; Dengler J; Jentsch-Ullrich K
Ann Hematol; 2024 May; 103(5):1569-1575. PubMed ID: 38472361
[TBL] [Abstract] [Full Text] [Related]
17. European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission.
Mahon FX; Pfirrmann M; Dulucq S; Hochhaus A; Panayiotidis P; Almeida A; Mayer J; Hjorth-Hansen H; Janssen JJWM; Mustjoki S; Martinez-Lopez J; Vestergaard H; Ehrencrona H; Machová Poláková K; Olsson-Strömberg U; Ossenkoppele G; Berger MG; Etienne G; Dengler J; Brümmendorf TH; Burchert A; Réa D; Rousselot P; Nicolini FE; Hofmann WK; Richter J; Saussele S; ;
J Clin Oncol; 2024 Jun; 42(16):1875-1880. PubMed ID: 38471049
[No Abstract] [Full Text] [Related]
18. Childbirth rates in women with myeloproliferative neoplasms.
Landtblom AR; Andersson TM; Johansson ALV; Lundberg FE; Samuelsson J; Björkholm M; Hultcrantz M
Leukemia; 2024 May; 38(5):1081-1085. PubMed ID: 38461191
[TBL] [Abstract] [Full Text] [Related]
19. Gene expression profiling on CML patients with Philadelphia translocation.
Alkhatabi H; Aldahlawi S; Hazzazi MS; Alsolami R; Elaimi A; Almashjary MN; Alserihi R; Alkhatabi HA; Alquthami ME; Daous YM; Bahashwan S; Yasin EB; Barefah A; Alsayes F
Eur Rev Med Pharmacol Sci; 2024 Feb; 28(4):1340-1355. PubMed ID: 38436167
[TBL] [Abstract] [Full Text] [Related]
20. Philadelphia chromosome-positive T-cell acute lymphoblastic leukemia: a case report.
Dong Q; Darwish T; Howard M; Shetty S; Wang Y; Xiu Y; Gallogly M; Zhao C
J Int Med Res; 2024 Feb; 52(2):3000605231156757. PubMed ID: 38422030
[TBL] [Abstract] [Full Text] [Related]
[Next]
